Artemether

蒿甲醚

Report date: 2022/02/11 15:01:38
NME

Base Information

Drug NameArtemether
Drug Alias Name甲基还原青蒿素ArtemtherinArtemeteroArtemisininelactol methyl etherArtemetherum +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsSolid tumoursMalaria, FalciparumMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaMalaria
Original Approved Country/TerritoryMainland China
Original Approved Date1990/01/01
Country/TerritorySenegalRwandaUnited Kingdom +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesKpc Pharmaceuticals IncChinese Academy Of Military Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKpc Pharmaceuticals Inc
Inactive CompaniesProto Pharma LtdCheikh Anta Diop University, SenegalLondonpharma Ltd
Active IndicationsMalaria
Inactive IndicationsSolid tumoursMalaria, Falciparum

Other Information

ATC CodeP01BE02
Related LinksWikipediaDrugBankKEGG